Iterum Therapeutics plc Gains 17.53%
Tue, Jul 27, 2021 at 05:33 PM
Iterum Therapeutics plc (ITRM:NASDAQ) shot up at $0.74, a gain of 17.5%. On Mon, Jul 26, 2021, ITRM:NASDAQ touched a New 2-Week Low of $0.63. The stock got featured on our News Catalysts scanner on Mon, Jul 26, 2021 at 01:34 PM in the 'BIOTECH' category. From Mon, Jul 12, 2021, the stock recorded 40.00% Up Days and 27.27% Green Days
The stock spiked on Mon, Jun 28, 2021 at $2.52 with a volume of 52M+.
About Iterum Therapeutics plc (ITRM:NASDAQ)
Iterum Therapeutics PLC is a clinical-stage pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally.
Top 10 Gainers:
- Oragenics, Inc. (OGEN:NYSEMKT), 34.14%
- SGOCO Group, Ltd. (SGOC:NASDAQ), 29.56%
- GX Acquisition Corp. (GXGX:NASDAQ), 27.18%
- BiondVax Pharmaceuticals Ltd. (BVXV:NASDAQ), 26.94%
- TAL Education Group (TAL:NYSE), 25.23%
- MOGU Inc. (MOGU:NYSE), 23.3%
- EyeGate Pharmaceuticals, Inc. (EYEG:NASDAQ), 20.83%
- IRSA Propiedades Comerciales S.A. (IRCP:NASDAQ), 20.37%
- JZXN (JZXN:NASDAQ), 19.16%
- Iterum Therapeutics plc (ITRM:NASDAQ), 17.53%